Lymph node expansion of CD4+ lymphocytes during antiretroviral therapy

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1378-1382

  Lafeuillade, Alain ^a,b   Chouraqui, Martine ^a   Hittinger, Gilles ^a   Poggi, Cécile ^a   Delbeke, Emmanuel ^a  

^a GENERAL HOSPITAL   (France)

^b Hopital Chalucet Toulon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; HLA DR ANTIGEN; INDINAVIR; LAMIVUDINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHOCYTE COUNT; LYMPHOID ORGAN; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030840334     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517326     Document Type: Article

References (17)

1. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995;333:1534-9.
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
3. + cell turnover [letter]. Nature 1995;375:193-4.
4. + cell turnover [letter]. Nature 1995;375:194.
5. + cell turnover [letter]. Nature 1995;375:194-5.
6. Phillips AN, Sabin CA, Mocroft A, Janossy G. HIV results in the frame. Antiviral therapy [letter]. Nature 1995;375:195.
7. Roederer M. T-cell dynamics of Immunodeficiency. Nature Med 1995;1:621-2.
8. + cell counts, and HIV-1 production by cells. Science 1996;271:670-1.
9. Tamalet C, Lafeuillade A, Fantini J, Poggi C, Yahi N. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS 1997;11:895-901.
10. Lane HC. The generation of CD4 lymphocytes in patients with HIV infection. J Biol Regul Homeost Agents 1995;9:107-9.
11. Bryan CF, Eastman PJ, Conner JB, Baier KA, Durham JB. Clinical utility of a lymph node normal range obtained by flow cytometry. Ann NY Acad Sci 1993;677:404-6.
12. Bürgisser P, Spertini F, Weyrich-Suter C, Pagani JL, Meylan PRA. Monitoring response to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration. J Infect Dis 1997;175:1202-5.
13. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997;276:960-4.
14. Clegg CH, Rulffes JT, Wallace PM, Haugen HS. Regulation of an extrathymic T-cell development pathway by oncostatin M. Nature 1996;384:261-2.
15. Zheng B, Han S, Zhu Q, Goldsby R, Kelsoe G. Alternative pathways for the selection of antigen-specific peripheral T cells. Nature 1996;384: 263-6.
16. Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990;171:801-17.
17. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alteration in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996;173:321-9.